Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection. | Ann Clin Microbiol Antimicrob | 2023 | 37986183 | PubTator, text mining | PubMed |
| Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives. | Clin Transl Med | 2023 | 37983927 | PubTator, text mining | PubMed |
| Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii. | BMC Immunol | 2023 | 37980458 | PubTator, text mining | PubMed |
| Mitochondria-associated membrane collapse impairs TBK1-mediated proteostatic stress response in ALS. | Proc Natl Acad Sci U S A | 2023 | 37967220 | PubTator, text mining | PubMed |
| Under-Fuelling for the Work Required? Assessment of Dietary Practices and Physical Loading of Adolescent Female Soccer Players during an Intensive International Training and Game Schedule. | Nutrients | 2023 | 37960161 | PubTator, text mining | PubMed |
| Protective Effects of Rhamnetin in Carbapenem-Resistant Acinetobacter baumannii-Induced Sepsis Model and the Underlying Mechanism. | Int J Mol Sci | 2023 | 37958587 | PubTator, text mining | PubMed |
| Naringenin attenuates inflammation and apoptosis of osteoarthritic chondrocytes via the TLR4/TRAF6/NF-κB pathway. | PeerJ | 2023 | 37953787 | PubTator, text mining | PubMed |
| 2-Pentadecyl-2-oxazoline inhibits lipopolysaccharide-induced microglia activation interfering with TLR4 signaling. | Life Sci | 2023 | 37952834 | PubTator, text mining | PubMed |
| Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis. | Sci Rep | 2023 | 37940672 | PubTator, text mining | PubMed |
| New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review. | Infect Dis Ther | 2023 | 37938418 | PubTator, text mining | PubMed |
| State-of-the-art polyetheretherketone three-dimensional printing and multifunctional modification for dental implants. | Front Bioeng Biotechnol | 2023 | 37929192 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37929034 | PubTator, text mining | PubMed |
| Non-invasive omics analysis delineates molecular changes in water-only fasting and its sex-discriminating features in metabolic syndrome patients. | MedComm (2020) | 2023 | 37929015 | PubTator, text mining | PubMed |
| Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study. | Heliyon | 2023 | 37928018 | PubTator, text mining | PubMed |
| Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review. | Front Pharmacol | 2023 | 37915415 | PubTator, text mining | PubMed |
| Cellular and molecular characteristics of the premetastatic niches. | Animal Model Exp Med | 2023 | 37902101 | PubTator, text mining | PubMed |
| Extracellular proteins as potential biomarkers in Sepsis-related cerebral injury. | Front Immunol | 2023 | 37901226 | PubTator, text mining | PubMed |
| Higher abundance of Campylobacter in the oral microbiome of Japanese patients with moyamoya disease. | Sci Rep | 2023 | 37899472 | PubTator, text mining | PubMed |
| Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics. | Pharmaceutics | 2023 | 37896221 | PubTator, text mining | PubMed |
| The Role of Intestinal Microbiota in Celiac Disease and Further Therapeutic Perspectives. | Life (Basel) | 2023 | 37895421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=16